RECRUITINGINTERVENTIONAL

Clinical Application of AI-assisted Ultrasound Technology in the Preoperative Evaluation of Thyroid Cancer

About This Trial

This study aims to explore the application of AI-assisted ultrasound technology in the preoperative assessment of thyroid cancer. Traditional ultrasound examination data from thyroid cancer patients will be collected, and AI systems will be utilized to detect and diagnose thyroid nodules and lymph nodes. In cases where there is disagreement between the two-dimensional ultrasound and AI system results, further confirmation will be sought through biopsy. Subsequently, pathological results will serve as the "gold standard" for comparison between the AI system and traditional ultrasound examination results, assessing their accuracy and reliability. Through this research endeavor, a more accurate and reliable method for preoperative assessment of thyroid cancer is aspired to be offered, thereby supporting clinical decision-making and paving the way for novel applications of AI in the field of medical imaging diagnosis.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with preoperative pathological confirmation of thyroid malignant tumors undergoing surgical treatment. - Patients with benign thyroid tumors, such as thyroid adenomas causing compressive symptoms, undergoing surgical treatment. - Patients with complete and high-quality traditional two-dimensional color ultrasound images. - Complete postoperative pathology reports. - Willingness to participate in this clinical trial and signing of willing to sign a consent form. Who Should NOT Join This Trial: - Patients with a history of neck surgery or radiotherapy. - Patients with a history of malignant tumors in other parts of the body. - Patients with thyroid dysfunction. - Incomplete or poor-quality traditional two-dimensional color ultrasound images. - Incomplete postoperative pathology reports. - Refusal to participate in this clinical trial. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Patients with preoperative pathological confirmation of thyroid malignant tumors undergoing surgical treatment. * Patients with benign thyroid tumors, such as thyroid adenomas causing compressive symptoms, undergoing surgical treatment. * Patients with complete and high-quality traditional two-dimensional color ultrasound images. * Complete postoperative pathology reports. * Willingness to participate in this clinical trial and signing of informed consent. Exclusion Criteria: * Patients with a history of neck surgery or radiotherapy. * Patients with a history of malignant tumors in other parts of the body. * Patients with thyroid dysfunction. * Incomplete or poor-quality traditional two-dimensional color ultrasound images. * Incomplete postoperative pathology reports. * Refusal to participate in this clinical trial.

Treatments Being Tested

DIAGNOSTIC_TEST

Supplementary Pathological Examination

For the same thyroid nodule, if there is discordance between the interpretations of AI-assisted ultrasound and traditional two-dimensional ultrasound, supplementary fine needle aspiration biopsy or intraoperative biopsy will be performed to clarify the nature of the nodule.

OTHER

No Need for Supplementary Pathological Examination

For the same thyroid nodule, if there is discordance between the interpretations of AI-assisted ultrasound and traditional two-dimensional ultrasound, there is no need for supplementary fine needle aspiration biopsy or intraoperative biopsy.

Locations (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China